We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Additional Deaths Raise More Questions About Natrecor's Safety Profile
Additional Deaths Raise More Questions About Natrecor's Safety Profile
January 4, 2006
Johnson & Johnson’s (J&J) embattled heart-failure medication Natrecor is again under fire after the company revealed this week that it failed to inform federal regulators about the deaths of two patients who participated in a clinical trial of the drug.